Next Generation Gene Editing and Genomic Engineering Tools Innovations and Therapeutic Applications

The ability to precisely modify genomic information has transformed modern biology and medicine, enabling direct interrogation and correction of genetic determinants underlying disease, development, and physiological function. Early gene manipulation strategies, although foundational, were constrained by limited specificity, low efficiency, and unintended genomic alterations. The emergence of next generation gene editing technologies has revolutionized genomic engineering by introducing programmable, highly precise, and adaptable tools capable of targeted DNA and RNA modification. Among these, CRISPR based systems have become the cornerstone of modern genome editing, offering unprecedented ease of design, scalability, and versatility. Building upon this foundation, advanced platforms such as base editing and prime editing have further refined genome manipulation by enabling single nucleotide changes and precise sequence insertions or deletions without inducing double strand DNA breaks. Parallel advances in epigenome editing and transcriptional control have expanded the scope of genomic engineering beyond sequence modification, allowing dynamic regulation of gene expression and chromatin architecture. These innovations have catalyzed rapid progress in therapeutic applications, including the treatment of inherited genetic disorders, cancer, infectious diseases, and regenerative medicine. However, challenges related to delivery efficiency, off target effects, immunogenicity, and ethical governance remain critical considerations for clinical translation. This review comprehensively examines the evolution of gene editing technologies, the mechanisms and innovations underlying next generation tools, and their expanding therapeutic and non medical applications, while addressing safety, ethical, and regulatory dimensions shaping the future of genomic engineering.